{"filing":{"accession_number":"0001062993-26-005411","cik":"0001498148","ticker":"AITX","company_name":"Artificial Intelligence Technology Solutions Inc.","form":"8-K","filing_date":"2026-10-20","report_date":"2026-10-20","primary_document":"form8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1498148/000106299326005411/form8k.htm"},"events":[{"id":36220,"run_id":33385,"accession_number":"0001062993-26-005411","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"summary":"The disclosure centers on management's projections of achieving monthly operating cash breakeven in January 2027 and all-in cash breakeven in Q2 2027, supported by an expanded cost-savings program ($345,000–$350,000 monthly reductions), workforce reductions, and strategic focus on three core platforms (SARA, RAIA, ROAMEO). While the filing explicitly disclaims these as non-GAAP projections and emphasizes going-concern doubt, the announcement of a material operational restructuring—including workforce reduction, vendor cuts, and strategic product focus—constitutes a significant operational event. The company's own language (\"hard decisions that affected people\") and the pausing of development on multiple platforms (AVA, ROSA, RIO, SARA Health/Fix) signal a material operational pivot. This is not a routine disclosure but a strategic repositioning with cash-flow implications, though it falls outside the specific categories of workforce_reduction (which typically includes a restructuring charge) or other defined types.","company_name":"Artificial Intelligence Technology Solutions Inc.","ticker":"AITX","filing_date":"2026-10-20","form":"8-K","submitted_at":null,"items":[{"id":40553,"accession_number":"0001062993-26-005411","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"The disclosure centers on management's projections of achieving monthly operating cash breakeven in January 2027 and all-in cash breakeven in Q2 2027, supported by an expanded cost-savings program ($345,000–$350,000 monthly reductions), workforce reductions, and strategic focus on three core platforms (SARA, RAIA, ROAMEO). While the filing explicitly disclaims these as non-GAAP projections and emphasizes going-concern doubt, the announcement of a material operational restructuring—including workforce reduction, vendor cuts, and strategic product focus—constitutes a significant operational event. The company's own language (\"hard decisions that affected people\") and the pausing of development on multiple platforms (AVA, ROSA, RIO, SARA Health/Fix) signal a material operational pivot. This is not a routine disclosure but a strategic repositioning with cash-flow implications, though it falls outside the specific categories of workforce_reduction (which typically includes a restructuring charge) or other defined types.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T10:06:19.558608+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40553,"accession_number":"0001062993-26-005411","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"The disclosure centers on management's projections of achieving monthly operating cash breakeven in January 2027 and all-in cash breakeven in Q2 2027, supported by an expanded cost-savings program ($345,000–$350,000 monthly reductions), workforce reductions, and strategic focus on three core platforms (SARA, RAIA, ROAMEO). While the filing explicitly disclaims these as non-GAAP projections and emphasizes going-concern doubt, the announcement of a material operational restructuring—including workforce reduction, vendor cuts, and strategic product focus—constitutes a significant operational event. The company's own language (\"hard decisions that affected people\") and the pausing of development on multiple platforms (AVA, ROSA, RIO, SARA Health/Fix) signal a material operational pivot. This is not a routine disclosure but a strategic repositioning with cash-flow implications, though it falls outside the specific categories of workforce_reduction (which typically includes a restructuring charge) or other defined types.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T10:06:19.558608+00:00","company_name":"Artificial Intelligence Technology Solutions Inc.","ticker":"AITX","filing_date":"2026-10-20"}]}